DSM-IV pain disorder in the general population: An exploration of the structure and threshold of medically unexplained pain symptoms by Fröhlich, Christine et al.
DSM-IV pain disorder in the general population  
An exploration of the structure and threshold of medically unexplained pain 
symptoms 
 
Christine Fröhlich,· Frank Jacobi, Hans-Ulrich Wittchen 
 
Received: 18 March 2005 / Accepted: 12 September 2005 / Published online: 18 November 2005    
 
Abstract 
 
Background Despite an abundance of questionnaire data, the prevalence of clinically significant and 
medically unexplained pain syndromes in the general population has rarely been examined with a rigid 
personal-interview methodology. Objective To examine the prevalence of pain syndromes and DSM-
IV pain disorder in the general population and the association with other mental disorders, as well as 
effects on disability and health-care utilization. Methods Analyses were based on a community sample 
of 4.181 participants 18–65 years old; diagnostic variables were assessed with a standardized 
diagnostic interview (M-CIDI). Results The 12-month prevalence for DSM-IV pain disorder in the 
general population was 8.1%; more than 53% showed concurrent anxiety and mood disorders. 
Subjects with pain disorder revealed significantly poorer quality of life, greater disability, and higher 
health-care utilization rates compared to cases with pain below the diagnostic threshold. The majority 
had more than one type of pain, with excessive headache being the most frequent type. Conclusions 
Even when stringent diagnostic criteria are used, pain disorder ranks among the most prevalent 
conditions in the community. The joint effects of high prevalence in all age groups, substantial 
disability, and increased health services utilization result in a substantial total burden, exceeding that 
of depression and anxiety.  
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Introduction 
 
Chronic pain is well known as a highly prevalent condition in the general population. 
However, population-based prevalence studies have provided only incomplete and quite 
inconsistent epidemiological characterization. For example, prevalence rates of pain vary 
from 2%–50% for the general population depending on varying methodological factors 
[48].Table 1 presents core results along with basic methodological information from recent 
epidemiological studies focussing on community surveys. Beyond “true” prevalence 
differences (e. g., due to cultural and ethnical factors [17]), this variability of prevalence rates 
can be largely attributed to critical issues in the assessment of pain and mental disorders in 
general, such as the conceptual level (coverage, symptoms vs. diagnosis), the time frame (e. 
g., 12 month vs. lifetime), and the assessment method (e. g., questionnaire vs. interview) [54, 
55]. Because of the complex nature of pain, the development of a comprehensive and 
coherent theoretical framework for chronic pain and a universally applicable and accepted 
classification system has proven difficult [29].As a result, there is also no universally accepted 
diagnostic instrument for epidemiological research in this domain. In the development of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM) [2–4], the diagnostic criteria of 
pain were tentatively specified and revised several times and finally labelled “pain disorder” 
in DSM-IV as a primarily descriptive and not etiological term. The specification also allowed 
for the first time the development of a standardized diagnostic interview approach to assess 
and clinically evaluate pain, but representative epidemiological studies using DSM-IV criteria 
are still not available [14]. The inclusion of a pain assessment module in recent diagnostic 
instruments, such as CIDI, also allows examination with greater precision of correlates and 
patterns of comorbidity with other mental disorders. The association of pain with other mental 
disorders, particularly depression, has been of interest for many years. Prevalence rates of 
major depression in pain patients range from 18%–54% [6, 13, 14, 36], compared to 2%–8% 
in the general population [e. g., 28, 51, 52]. The increasing prevalence of chronic pain is 
associated with an increasing number of depressive symptoms; in addition, nearly every 
second respondent diagnosed with major depression reports also experiencing pain [40]. Bair 
et al. [5] point out that the presence of depression in pain patients is associated with more pain 
complaints and greater impairment and that the presence of pain in depressive patients effects 
quality of life, occupational functioning, and health-care utilization. Findings with regard to 
the chronological order of pain and comorbid conditions are heterogeneous. Fishbain et al. 
[18] reviewed 83 clinical and epidemiological studies with regard to several hypotheses on the 
comorbidity of pain (e. g., antecendent, consequence, or cognitive-mediation 
hypothesis).According to this review, pain precedes depression in most comorbid cases (i. e., 
there is stronger evidence for depression as a consequence of pain). Prospective studies 
indicate a bidirectional association, rather than a simultaneous beginning [e. g., 11, 35, 37]. 
Less attention is paid to comorbidity with anxiety disorders although data imply an 
association at least as strong as that which occurs with depression [38, 49]. Because of these 
inconsistent findings, the inconsistent definitions of “chronic pain”, and the absence of 
representative studies using DSM-IV criteria for pain disorder, the aims of the present study 
were to examine (1) the prevalence of clinically significant and medically unexplained pain 
symptoms as well as of DSM-IV pain disorder in the general population; (2) the type and 
strength of associations of pain symptoms/DSM-IV pain disorder with mood, anxiety, and 
substance disorder; and (3) the association with disability days, quality of life, and health-care 
utilization.  
 
 
Methods 
 
Findings are based on the Mental Health Supplement of the German National Health 
Interview and Examination Survey 1998/99 (GHSMHS). Aims, design, and methods have 
been described in greater detail elsewhere [8, 26].Therefore, design and sample characteristics 
are only briefly discussed here. 
 
Sample 
 
The GHS covered a range of medical and social assessments in a multistage stratified random 
sample of the general German population from 18 to 79 years of age, drawn from population 
registries (N=7.124; response rate: 61%). The mental health supplement covered a subsample 
of this population (N=4.181; response rate within that subsample: 87.6 %) and can be 
regarded as representative for the German non-instutionalized adult population from 18 to 65 
years of age. GHS respondents older than 65 years were excluded because of unsatisfactory 
psychometric properties of the diagnostic interview for use in older populations [30]. 
 
Assessment 
 
The assessment of mental disorders was based on the computer-assisted version of the 
Munich Composite International Diagnostic Interview (DIA-X/M-CIDI; [57, 59]), 
administered by clinically trained interviewers (psychologists and MDs). The M-CIDI is a 
fully structured interview that allows the assessment of symptoms and syndromes, as well as 
4-week, 12-month, and selected lifetime diagnoses of a wide range of mental disorders, based 
on DSM-IV [4] and ICD- 10 [60]. Psychometric properties of the M-CIDI were found to 
range from “acceptable” to “very good” [32, 42, 56, 59].All subsequent analyses were 
performed for 12-month criteria.  
 
Pain symptoms and DSM-IV pain disorder.  
Diagnostic criteria for DSM-IV pain disorder are presented in Table 2. In the M-CIDI, first 
the presence of the following painful conditions in the past 12 months was assessed: excessive 
abdominal pain, excessive back pain, joint pain, limb pain, chest pain, excessive headache, 
excessive painful menstruation, rectal and genital pain, and other pain. Whenever the 
respondent acknowledged having experienced at least one of these pain types, the interviewer 
entered a standardized complex set of probe questions to evaluate the nature of the complaint 
[45, 58].There are several levels of probing before the symptom ultimately is considered 
“medically unexplained”. The probe questions started with establishing clinical severity with 
respect to significance (criterion A [4]).A symptom was considered clinically significant if 
any of the following conditions are met: (1) the symptom prompts help-seeking behavior with 
a medical doctor or (2) another health professional; (3) medication was taken more than once 
for it; or (4) the symptom interfered substantially with life or activity. The next probe 
questions targeted whether any somatic/substance- related factors might explain the 
occurrence of the symptom. If there was at least one significant occasion where the symptom 
was not entirely explained by medical diagnosis, use of medication or drugs, injuries, or 
combinations of these, the symptom was rated as unexplained (or somatoform). If at least one 
painful condition was found to be present as clinically relevant, further questions were asked 
to assess the diagnosis of DSM-IV pain disorder (criterion B [4]): (1) Did the pain ever last 
for a period of at least six months? (2) Did the pain ever prevent you for a period of six 
months from meeting your friends and family and from doing your work? (3) How strongly 
did the pain interfere with your life and activities (a little, a lot, or very much)? If the 
respondent acknowledged impairment for six months or at least a substantial interference with 
daily living, the diagnosis of DSM-IV pain disorder was given. For the main diagnostic 
category “any somatoform disorder”, the retest reliability of the M-CIDI (1 week) as well as 
validity (concordance of interview and clinician’s diagnoses in a clinical sample) were lower 
compared to depressive and anxiety disorders but still acceptable (kappa=0.50–0.62 [42, 58, 
59]).  
 
Mental disorders. 
 The following DSM-IV mental disorders were considered for the subsequent analysis: 
dependence and abuse of alcohol/ illicit substances, mood disorders (major depression, 
dysthymia, bipolar disorders), and anxiety disorders (panic disorder, social phobia, any 
specific phobia, generalized anxiety disorder (GAD), obsessive-compulsive disorder). The 
temporal relation among disorders in comorbid cases was assessed by using retrospective, 
self-reported ages-of-onset data.  
 
Sociodemographic correlates, impairment, and health-care utilization. 
The following sociodemographic correlates of DSM-IV pain disorder were examined: sex, 
age, marital status, education, employment status, and social class (derived from information 
on education, income and current (job) position [50]). Impairment was examined first by the 
self-reported number of disability days in terms of being unable to carry out usual daily 
activities within the past 12 months. Second, health-related quality of life (SF-36 [12, 50]) 
was presented as a physical and a mental health score (standardized to M=50, SD=10). The 
assessment of health-care utilization included self-reported data on primary care visits, 
consultations with specialists (12 domains, including neurologists, psychiatrists, and 
psychologists), and days spent in hospital within the past 12 months.  
 
Analytic strategy 
 
Statistical analyses were done with the STATA software package, version 8.0 [46]. Presented 
prevalence estimates (N, %) were calculated with the data weighted for age, gender, region, 
and screening status in order to address different sampling probabilities and systematic 
nonresponse [26].Multinominal logistic regression models (odds ratios with 95% confidence 
intervals) were used to quantify associations between DSM-IV pain disorder and several 
covariates (e. g., comorbid mental disorders, sociodemographic correlates). Associations with 
count variables (e. g., impairment days, number of comorbid disorders) were assessed with 
mean ratios (MRs) from negative binomial regression [25, 33]. MRs meet the positively 
skewed distribution of infrequent events and reflect the change in the expected count of a 
particular event per unit-increase in the covariate. For SF-36 (mental health) and SF-36 
(physical health), the inversed ratios from a gamma regression were used to determine size 
and statistical significance of the differences among groups. All comparisons were controlled 
for age.  
 
 
Results 
 
Prevalence of pain symptoms and DSM-IV pain disorder 
 
Table 3 shows 12-month prevalences of pain symptoms considered as being clinically 
significant and medically unexplained, as well as DSM-IV pain disorder in the general 
population. All pain symptoms as well as DSMIV pain disorder were more frequent in 
women. Excessive headache was the most frequent painful condition (total sample: 12.7%; 
men: 8.2%; women: 16.7 %), consistent over all age groups. Abdominal pain and excessive 
back pain were also often reported (total: 8.3% and 8.5%, respectively); in women, excessive, 
painful menstruation was very common, peaking at age 18–34 with 21.6%. Of the sample, 
28% (men: 22.4%; women: 34.2 %) reported at least one pain symptom without meeting 
criteria for DSM-IV pain disorder, and 8.1 % met the criteria for DSM-IV pain disorder (men: 
4.3%; women: 11.4 %). If the exclusion criteria of somatization disorder or undifferentiated 
somatization disorder/Somatic Symptom Index (SSI4.6) according to Escobar et al. (1989) 
[17] were applied, the number decreased to 6.4% (men: 3.9%; women: 8.9 %). If the 
diagnosis of DSM-IV pain disorder was given, in most cases (55%) multiple pain symptoms 
were reported; 8.1% reported four or more symptoms. If clinically significant, medically 
unexplained pain symptoms were present, men reported a pure pain symptom more often than 
did women (78.3% vs. 61%); in DSM-IV pain disorder, the number of combined symptoms 
was about the same in men and women except for the category of four or more 
symptoms,which was more frequent in women (9.7 % vs. 4.2 %). We also examined the 
prevalence of DSM-IV pain disorder by pain site (not shown in Table 3), revealing that in the 
total sample, 3.8% had a DSM-IV pain disorder associated with excessive headache, 2.3% 
with excessive back pain, 2.1% with excessive abdominal pain, 1.9% with joint pain, 1.5% 
with chest pain, 1.3% with limb pain, and 0.3% with rectal and genital pain or other pain.  
 
Association of pain with mental disorders 
 
We examined the prevalence of major comorbid diagnostic subgroups and the mean number 
of 12-month disorders in the groups having (a) no pain symptoms, (b) any clinically relevant 
pain symptom, and (c) DSMIV pain disorder.As compared to subjects without pain 
symptoms, rates for mental disorders were strongly elevated in subjects meeting criteria for 
DSM-IV pain disorder, with GAD (7.1%; OR=7.31; CI: 4.32–12.37) and dysthymia (16.7%; 
OR=5.63; CI: 4.01–7.92) being the most elevated comorbid diagnoses. Substance-use 
disorders tended also to be more frequent in subjects with DSM-IV pain disorder (men: 9.9% 
vs. 6.4% without pain symptoms; women: 3.1% vs. 1.7%), but this increase in frequency did 
not reach statistical significance. In subjects with DSM-IV pain disorder, 56% met the 
diagnostic criteria for any other 12-month disorder (vs. 33.5% without pain disorder; 
OR=2.56; CI: 1.96–3.35) and showed a mean number of 2.4 comorbid 12-month disorders 
(vs. 1.6; MR=1.48; CI: 1.36–1.62). Having more than one pain symptom increased the 
comorbidity with all examined mental disorders, even significantly for any 12-month 
disorder, mean number of 12-month disorders, and any anxiety disorder. Because of 
noticeable sex differences in comorbidity rates, comorbid pain symptoms and DSM-IV pain 
disorder are presented separately for men and women (Table 4).Women showed higher 
prevalence rates of all disorders as well as higher comorbidity rates in cases with any pain 
symptom (except for any substance abuse/dependence). The increase of additional diagnoses 
with vs. without pain disorder was higher in males, especially for GAD (men: 8%; OR=13.00; 
CI: 5.12–31.10 vs. women: 6.7%; OR=4.91; CI: 2.58–9.33). Further analyses of depressive 
symptom patterns in persons with and without pain disorder revealed a slightly greater 
number of depressive symptoms in men than in women; this increase was not specific to 
somatic symptoms because cognitive and affective symptoms were significantly elevated as 
well (not presented in tables). In an examination of the prevalence of DSM-IV pain disorder 
by pain site (not shown in Table 4), joint and limb pain were found to be highly comorbid 
with mental disorders compared to the other pain symptoms under consideration. DSM-IV 
pain disorder associated with limb pain showed the greatest comorbidity with any 12-month 
disorder (81.3%; OR=3.60; CI: 1.64–7.90), especially in men (84.4%; OR=5.37; CI: 1.36–
21.20). In contrast, DSM-IV pain disorder associated with excessive back pain showed 
relatively lower comorbidity rates.  
 
Correlates and effects of pain syndromes and pain disorder on impairment and health-care 
utilization 
 
Sociodemographic correlates. 
Sociodemographic correlates for DSM-IV pain disorder were found to be female sex 
(OR=2.48; CI: 1.92–3.20) and unemployment compared to working fulltime (OR=2.10; CI: 
1.37–3.22). Subjects from the lower social class showed elevated rates compared to those of 
medium or high social class (OR=1.48; CI: 1.07–2.06).  
 
Impairment and health care utilization. 
Table 5 shows (1) impairment in terms of number of disability days and quality of life and (2) 
different domains of healthcare utilization in subjects with any pain symptom and DSM-IV 
pain disorder. Because we found no significant sex differences (although men tended to have 
more disability days and visits with specialists and primary care visits), results are shown for 
the total sample. The diagnosis of DSM-IV pain disorder is significantly associated with 
impairment and health-care utilization for all variables under consideration. Whereas subjects 
having no pain symptoms and any clinically significant pain symptom reported fewer 
disability days than did the total sample (12.9), the mean number of disability days was 
significantly increased in subjects with diagnosed DSM-IV pain disorder (29.7; MR=2.55; CI: 
1.99–3.27). Quality of life with regard to mental health (SF-36) was significantly reduced in 
subjects with any pain symptom; this effect was much stronger in subjects with DSM-IV pain 
disorder. The physical component of the SF-36 was decreased only in DSM-IV pain disorder. 
The mean numbers of visits in general practice, specialist visits, and number of days in 
hospital were increased in subjects with any pain symptom, and even more in those with a 
diagnosis of DSM-IV pain disorder (e. g., number of days in hospital: 2.6; MR=1.91; CI: 
1.28–2.84). Findings were not as pronounced but still significant after having been controlled 
for duration of pain or comorbidity with mental disorders and somatic conditions. To check 
whether the effects were better explained by comorbidity than pain itself, we conducted the 
same analyses for pure DSM-IV pain disorder (43%, N=148).Effects remained significant for 
number of disability days and doctor visits (specialists and primary care). In an analysis of 
pain symptoms separately in subjects with diagnosed DSM-IV pain disorder (not shown in 
Table 5), the number of pain symptoms was strongly associated with all impairment 
measures; however, we found no special pain symptom related to increased impairment or 
health-care utilization in the total sample, either in men or in women.  
 
 
Discussion 
 
This is to our knowledge the first community study examining the prevalence and selected 
correlates of medically unexplained and clinically significant pain symptoms as well as pain 
disorder according to the rigid criteria of DSM-IV. Unlike most other studies, prevalence 
estimates reported here are based on a careful exploration of the symptom level by use of a 
standardized diagnostic module administered by clinical interviewers and using an objective, 
computerized diagnostic analysis. Limitations are (1) a restricted range of pain types assessed, 
(2) the lack of diagnostic routine medical appraisal of symptoms, (3) the sole reliance on a 
cross-sectional assessment without chart information, and (4) a restricted age range. 
Respondents older than 65 years were not considered because the psychometric properties for 
such interview tools in older populations have not yet been established [30].  
 
Prevalence of pain. 
Even with our more stringent complex interview approach, medically unexplained and 
clinically significant symptoms of pain were found to be a highly prevalent phenomenon in 
the general population: 22% of all males and 34% of all females reported having experienced 
at least one such problem during the past 12 months. Consistent with previous findings [e. g., 
35, 40] excessive headache, abdominal pain, excessive back pain, and painful menstruation in 
women were the most frequent painful conditions in the total sample as well as in subjects 
with diagnosed DSMIV pain disorder. Prevalence rates for specific pain types ranged from 
0.6% (other, not specified pain) to 13% (excessive headache).Although similar high 
frequencies have been reported elsewhere [e. g., 1, 13, 15, 16, 21], direct comparisons with 
previous studies are difficult and restricted because most studies used a different range and 
scope of symptoms [14]. Using the DSM-IV diagnostic criteria, the study findings revealed 
that one out of four subjects with pain symptoms also met the criteria for DSM-IV pain 
disorder. The 12-month prevalence estimates of 8% (men: 4%; women: 11%) make this the 
most prevalent of all 12-month mental disorders in the general population. This estimate lies 
between the much higher rates of questionnaire-type studies and the lower rates of psychiatric 
diagnostic investigations. Because there is still a lack of consensus with regard to uniformly 
accepted definitions and assessments of pain and a dearth of coherent theoretical and 
methodological evidence, diagnoses based on DSM-IV criteria are a reasonable 
methodological refinement, for example, by facilitating comparisons of prevalence rates 
across different studies [14, 29]. In this regard it has to be kept in mind that neither DSM-IV 
nor epidemiological research conceptualize mental disorders as nosological entities with 
clear-cut boundaries. This is a basic problem in our current research practice for which there 
are no solutions yet. Although it is claimed that the criteria offer the best comprehensive 
reliable diagnosis and classification of pain – regardless of the pain manifestation – available 
today, Sullivan [47] criticizes DSM-IV pain disorder as “a diagnosis of exclusion”, providing 
neither clear criteria for diagnosis nor implications for therapy, indicating that we are still not 
close to a perfect method of diagnosing this condition.  
 
Association of pain with other mental disorders. 
56% of the cases with DSM-IV pain disorder met the criteria of at least one other mental 
disorder. Findings confirm that comorbidity seems to be the rule rather than the exception [54, 
55]. DSM-IV pain disorder revealed high comorbidity rates in particular with depressive 
(30%) and anxiety disorders (35 %). The novelty of this finding lies in the fact that it provides 
evidence for the presence of full-blown threshold mental disorders with DSM-IV pain 
disorder and not merely an association with syndromes. In longitudinal studies, pain and 
major diagnostic subgroups showed a bidirectional association, with a prevalent prior onset of 
pain in comorbid cases with depressive and substance-use disorders [11, 18, 35, 37].We did 
not report temporal patterns here because of methodological limitations (age of onset was 
assessed only retrospectively), but our data are consistent with these findings (e. g., pain as 
the primary condition in 75% of pain cases comorbid with depression, supporting the 
hypothesis of depression being a consequence of pain). The association with depressive 
disorders is well documented [e. g., 7, 13, 21, 24, 40, 49], but the exact mechanism has not yet 
been properly established [6, 39]. Since most of this knowledge can be drawn from clinical 
studies, further research should examine cognitive and behavioral factors in this association as 
well as shared psychopathological mechanisms and pathways that are consistent in particular 
with the consequence hypothesis. However, for the subgroup of comorbid cases without an 
earlier onset of threshold pain disorder, other mechanisms might be applied. Pain symptoms 
that exist for a long time without fulfilling the criteria for pain disorder can, for example, 
achieve a completely different quality (e. g., decreased pain tolerance) in the context of a 
major depressive episode without necessarily “causing” the depression or “being caused”by 
the depression; additionally, a predisposition to depressive symptoms may increase the 
likelihood for the development of a full-blown depression in some pain patients. These kind 
of mechanisms correspond to the “scar hypotheses” that is supported in several studies [18]. 
Current treatment strategies for pain do include some components that are used in depression 
treatment as well (e. g., establishment and maintenance of positive activities, increasing self-
functioning), but overall the frequent comorbidity seems not to be adequately covered. It can 
be assumed already under current conditions – even though the interplay between pain and 
comorbid mental disorders is not yet satisfactorily explained – that it is important to include 
and implement knowledge about the comorbidity of pain more explicitly in treatment.  
 
Gender differences. 
Women showed higher rates of all pain symptoms examined, DSM-IV pain disorder, and 
number of combined pain symptoms. If the diagnosis of DSM-IV pain disorder is given, men 
show significantly higher comorbidity rates for all mental disorders, with GAD and dysthymia 
being the most frequent comorbid disorders. The association of pain disorder with other 
mental disorders was more pronounced in males (e. g., mood disorders: 7% without vs. 30% 
with pain disorder) as compared to females (15 % vs. 30 %). This could lead to the 
assumption that that DSM-IV pain disorder works as a stressor especially in men [see also 19, 
23]. It may also be suggested that in terms of a “masked” depression [9], men report more 
somatic symptoms because of an inability to communicate depressive feelings. This view is 
not supported by closer analyses of depressive symptom patterns: the number of somatic 
symptoms of depression were more elevated in men than in women, but this increase was not 
specific to somatic symptoms because in comorbid cases cognitive and affective symptoms 
were significantly elevated as well.  
 
Impairment and health-care utilization. 
Pain was associated with extraordinary rates of disability days, substantially reduced physical 
and mental well-being, and highly increased rates of health-care utilization in several different 
domains. The associations were already pronounced for any clinically significant pain 
syndrome and even more pronounced for DSM-IV pain disorder, even exceeding those of 
depression and anxiety. The commonly reported major effect of comorbidity on impairment 
for mental disorders in general [e. g., 21, 22] and for pain and depression in particular [6] was 
confirmed in this study, but disability days and health-care utilization were significantly 
increased in cases without comorbidities as well. The effects of the diagnosis of DSM-IV pain 
disorder remained stable after having been controlled for sex, age, duration of pain, or 
comorbidity with mental and physical disorders, suggesting that DSM-IV pain disorder itself 
is strongly associated with impairment, decreased self-rated health status, and increased 
health-care utilization.  
 
Implications. 
The value of the data lies in the demonstration that (a) even using stringent diagnostic criteria, 
8% of the general population meet criteria for pain disorder and that (b) pain disorder is 
associated with high comorbidity of DSM-IV depressive and anxiety disorders (which cannot 
be explained solely by symptom overlap), as well as reduced rates of quality of life and 
impairment. The joint effects of high prevalence in all age groups, substantial disability, and 
reduced quality of life, as well as increased health-services utilization result in a substantial 
total burden, exceeding that of depression and anxiety. The data further indirectly highlight 
the considerable degree of unmet need for treatment in patients with pain disorder.  
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